Company Origin Therapeutics Holdings Inc. Canadian Securities Exchange

Equities

ORIG

CA68622H1073

Investment Management & Fund Operators

End-of-day quote Canadian Securities Exchange 23:00:00 04/02/2024 GMT 5-day change 1st Jan Change
0.115 CAD -11.54% Intraday chart for Origin Therapeutics Holdings Inc. -14.81% -39.47%

Business Summary

Safe Supply Streaming Co Ltd. is engaged in investing in the legal and regulated supply of drugs. The Company’s focus is investing and incubating companies across the ecosystem to address the physical, financial, and emotional damage from drug abuse with products, solutions and technologies. Its portfolio includes CannaLabs, and Safe Supply Licensing Co. CannaLabs is licensed by Health Canada, engaged in conducting cutting-edge research on methylenedioxymethamphetamine (MDMA), cocaine, dimethyltryptamine, ketamine and other psychoactive compounds that will be foundational to the development of the safe supply ecosystem. It is also engaged in conducting analytics and testing for compounds manufactured in Canada or imported. Safe Supply Licensing Co is an application process for a dealers’ license pursuant to the Controlled Drugs and Substances Act (CDSA) to be able to import and test controlled substances to connect investee companies to a federal license for Schedule 1 - 3 compounds.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 76,923,225 71,969,474 ( 93.56 %) 0 93.56 %

Shareholders

NameEquities%Valuation
Apolo Capital Advisory Corp.
6.123 %
4,710,001 6.123 % 80 070 $
1,177,500 1.531 % 20 018 $
140,000 0.1820 % 2 380 $
Ronan Levy
0.1300 %
100,000 0.1300 % 1 700 $
3,750 0.004875 % 64 $
Jack Bensimon
0.000000 %
0 0.000000 % - $
Franco Salvati
0.000000 %
0 0.000000 % - $
James Obaji
0.000000 %
0 0.000000 % - $
  1. Stock Market
  2. Equities
  3. SPLY Stock
  4. ORIG Stock
  5. Company Origin Therapeutics Holdings Inc.